Precautions
Reserve its use in patients who are unable to tolerate any other treatments e.g. methimazole, radioactive iodine or surgery.
Inform patient of liver failure risk and tell them to report any signs of liver dysfunction (e.g. loss of appetite, nausea, vomiting, pruritus, dark coloured urine, light coloured stools, jaundice, right upper-quadrant pain) or agranulocytosis (e.g. fever, sore throat) immediately.
Stop treatment upon seeing signs of agranulocytosis, aplastic anaemia, fever, liver injury, elevated LFT above 3 times the upper limit of normal or exfoliative dermatitis.
Regular monitoring of thyroid function and CBC is advisable. Monitor prothrombin time regularly during treatment, especially before surgical procedures.
Interactions
Benzylthiouracil may potentiate the activity of anticoagulants. Doses of β-blockers, digitalis glycosides and theophylline may need to be reduced when patient becomes euthyroid.